Drug Discovery Market Research Reports

"...... e times higher than a developed country like the U.S. Also, innovations in China are significantly improving. Over the past few years, the Indian pharmaceutical companies, too, have been attempting to re-orientate their efforts toward developing new ......"

"...... ehensive and updated technology. Also, the healthcare spending of European countries is increasing considerably. The U.K drug discovery market accounted for the most significant revenue share in 2017. Other significant contributors included Germany, ......"

"...... al advancement in cardiology are chiefly driving the demand for North American drug discovery market. More than 90 million Americans carry a diagnosis of CVD. However, US has the world's finest hospitals and clinics for cardiology surgeries and other......"

"...... een the forecast years of 2018-2026. Market Insights Technology-wise, the global drug discovery market is segmented into Protein Microarrays, QPCR, Mass Spectrometry, DNA Microarrays, High Throughput Screening, Protein and Nucle......"

"...... Market Insights The market is segmented on the basis of plant-derived drug type, products, and therapeutic applications. These drugs are less toxic in nature as compared to traditional methods. Indian botanical and plant derivative dru......"

"...... es, their growing applications in diseases and the increasing number of approvals from the FDA are chiefly responsible for driving the market growth. The rising prevalence of asthma is likely to augment the demand for botanical drugs in the European ......"

"...... and products as key dietary supplements. However, only a few products have been approved by the United States Food and Drug Administration (FDA) for deployment as prescription drugs. The increasing approval by FDA for botanical drugs and their escal......"

"...... ted to reach a worth of $53850 million by its end. Market Insights The global botanical and plant-derivative drug market is segmented on the basis of types, products and therapeutic applications. The type segment of the market i......"

"...... ological advancements in HCS solutions during the forecast period. The rapid growth in developing countries across APAC is also expected to provide an opportunity for revenue generation in the market. However, the high cost of HCS instruments and the......"

"...... ug discovery process is based on target identification and screening for drug candidates. The label-free technologies are used for studying biomolecular interactions and eliminate the confounding effects of spatial interference, auto fluorescent or q......"